NuCana (NCNA) Profit After Tax (2017 - 2025)
NuCana's (NCNA) quarterly Profit After Tax came in at -$3.3 million in Q4 2025, down 294.39% year-on-year from $1.7 million in Q4 2024, and down 771.76% quarter-over-quarter from -$379170.8 in Q3 2025.
NuCana (NCNA) Profit After Tax (2017 - 2025) Analysis & Trends
NuCana has disclosed Profit After Tax across 9 years of filings, most recently posting -$3.3 million for Q4 2025.
- Profit After Tax for Q4 2025 came in at -$3.3 million, down 294.39% year-over-year; the trailing twelve-month figure through Dec 2025 was $25.4 million (up 487.67% YoY), and the FY2025 annual result was -$38.7 million, down 59.38% from the prior year.
- Profit After Tax came in at -$3.3 million for Q4 2025 at NuCana, down from -$379170.8 in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $32.2 million in Q2 2025 to a low of -$18.4 million in Q4 2021.
- The 5-year median for Profit After Tax is -$5.6 million (2022), against an average of -$3.1 million.
- Peak annual rise in Profit After Tax reached 268.77% in 2021, while the deepest fall reached 364.75% in 2021.
- NuCana's Profit After Tax stood at -$18.4 million in 2021, then gained by 3.07% to -$17.8 million in 2022, then soared by 46.71% to -$9.5 million in 2023, then surged by 91.18% to -$838126.7 in 2024, then plunged by 294.39% to -$3.3 million in 2025.
- The last three Profit After Tax figures came in at -$3.3 million (Q4 2025), -$379170.8 (Q3 2025), and $32.2 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 30.90 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | -14.46 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | -3.63 Mn |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | -753,254.00 |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 1.03 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -56.74 Mn |
| 10 | NuCana | 29.13 Bn | 29.13 Bn | - | -3.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.31 Mn |
| Sep 30, 2025 | -379,170.76 |
| Jun 30, 2025 | 32.17 Mn |
| Mar 31, 2025 | -3.11 Mn |
| Dec 31, 2024 | -838,126.70 |
| Sep 30, 2024 | -5.86 Mn |
| Jun 30, 2024 | 8.83 Mn |
| Mar 31, 2024 | -8.67 Mn |
| Dec 31, 2023 | -9.50 Mn |
| Sep 30, 2023 | -8.48 Mn |
| Jun 30, 2023 | 6.77 Mn |
| Mar 31, 2023 | -9.56 Mn |
| Dec 31, 2022 | -17.83 Mn |
| Sep 30, 2022 | -5.34 Mn |
| Jun 30, 2022 | 4.90 Mn |
| Mar 31, 2022 | -11.28 Mn |
| Dec 31, 2021 | -18.39 Mn |
| Sep 30, 2021 | -11.09 Mn |
| Jun 30, 2021 | 12.70 Mn |
| Mar 31, 2021 | -13.46 Mn |